Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca M Elli

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Clinical Endocrinology and Metabolism|January 20, 2012
Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophsErika Peverelli, Giovanna Mantovani, Eleonora Vitali, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patientsGiovanna Mantovani, Luisa de Sanctis, Anna Maria Barbieri, et al.
Histopathology|February 28, 2017
Fibrocartilaginous mesenchymoma of bone: a single-institution experience with molecular investigations and a review of the literatureMarco Gambarotti, Alberto Righi, Daniel Vanel, et al.
European Journal of Human Genetics : EJHG|July 10, 2014
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA studyIntza Garin, Giovanna Mantovani, Urko Aguirre, et al.
European Journal of Human Genetics : EJHG|March 13, 2015
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA studyIntza Garin, Giovanna Mantovani, Urko Aguirre, et al.
The Journal of Clinical Endocrinology and Metabolism|January 17, 2015
Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanismsIntza Garin, Francesca M Elli, Agnes Linglart, et al.
European Journal of Endocrinology|July 13, 2016
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP networkSusanne Thiele, Giovanna Mantovani, Anne Barlier, et al.
Nature Reviews. Endocrinology|July 1, 2018
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus StatementGiovanna Mantovani, Murat Bastepe, David Monk, et al.
Hormone Research in Paediatrics|August 7, 2020
Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and PatientsGiovanna Mantovani, Murat Bastepe, David Monk, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Clinical Endocrinology and Metabolism|January 20, 2012
Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophsErika Peverelli, Giovanna Mantovani, Eleonora Vitali, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patientsGiovanna Mantovani, Luisa de Sanctis, Anna Maria Barbieri, et al.
Histopathology|February 28, 2017
Fibrocartilaginous mesenchymoma of bone: a single-institution experience with molecular investigations and a review of the literatureMarco Gambarotti, Alberto Righi, Daniel Vanel, et al.
European Journal of Human Genetics : EJHG|July 10, 2014
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA studyIntza Garin, Giovanna Mantovani, Urko Aguirre, et al.
European Journal of Human Genetics : EJHG|March 13, 2015
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA studyIntza Garin, Giovanna Mantovani, Urko Aguirre, et al.
The Journal of Clinical Endocrinology and Metabolism|January 17, 2015
Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanismsIntza Garin, Francesca M Elli, Agnes Linglart, et al.
European Journal of Endocrinology|July 13, 2016
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP networkSusanne Thiele, Giovanna Mantovani, Anne Barlier, et al.
Nature Reviews. Endocrinology|July 1, 2018
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus StatementGiovanna Mantovani, Murat Bastepe, David Monk, et al.
Hormone Research in Paediatrics|August 7, 2020
Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and PatientsGiovanna Mantovani, Murat Bastepe, David Monk, et al.
Pageof 2